The final pH of CASO broth was 7.3 ± 0.2 at 25 °C. Commercial MRS broth (Merck, Darmstadt, Germany) was rehydrated in distilled water according to manufacturer's instructions, and hydrochloric acid (1 ...

Amid concerns over rising petroleum prices and resource depletion, organic compounds such as methanol are attracting ...

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma unveiled a pair of phase 3 wins for enlicitide decanoate in patients with ...

Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance ...

When Merck & Co. | After Merck paid a hefty sum to co-develop and co-commercialize HER3-DXd, the drug has suffered notable setbacks in consecutive years.

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.

Folic acid is a synthetic form of vitamin B9 that's often added to fortified foods and used in supplements. Learn about its benefits and sources, your risk of deficiency, and more.

Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff.

Merck gets lift from U.S. patent office in battle over injectable form of Keytruda Dispute with Halozyme Therapeutics could affect plans to extend its franchise product Manage alerts for this article ...

RAHWAY, N.J., May 27, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend ...

MERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times (FT) reported on Monday, citing three people familiar with the matter. MoonLake's ...